Display options
Share it on

Oncol Lett. 2017 Apr;13(4):2237-2243. doi: 10.3892/ol.2017.5687. Epub 2017 Feb 07.

Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC.

Oncology letters

Yinzhou Xiang, Fen Li, Lei Wang, Anyuan Zheng, Jingjing Zuo, Man Li, Yongping Wang, Yong Xu, Chen Chen, Shiming Chen, Bokui Xiao, Zezhang Tao

Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.
  2. Research Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

PMID: 28454386 PMCID: PMC5403261 DOI: 10.3892/ol.2017.5687

Abstract

Calpains are a family of intracellular cysteine proteases involved in various biological processes. Previously, the family was identified to have abnormal expression in several types of malignant tumor. Calpain 6 was less well known; however, it was recently identified to be involved in the carcinogenesis of certain types of malignant tumor. However, the expression of calpain 6 in head and neck squamous cell carcinoma (HNSCC) remains unclear. A total of six datasets from the Gene Expression Omnibus (GEO) was analyzed and an association between calpain 6 expression levels and HNSCC was identified, with the expression of calpain 6 observed to be significantly decreased in HNSCC (P<0.01). However, the expression of calpain 6 may vary between distinct tumor stages of HNSCC. Furthermore, calpain 6 expression was positively associated with the survival rate in patients with HNSCC (P<0.05), with increased expression of calpain 6 associated with an improved survival outcome. Calpain 6 expression was analyzed using an HNSCC tissue microarray and these results were consistent with the statistical analysis of the bioinformatics data from the GEO, indicating that calpain 6 may be a tumor suppressor protein in HNSCC.

Keywords: Gene Expression Omnibus; calpain 6; head and neck squamous cell carcinoma; tissue microarray; tumor stage

References

  1. PLoS Genet. 2010 Jul 29;6(7):e1001040 - PubMed
  2. Cancer Sci. 2016 Oct;107(10 ):1443-1452 - PubMed
  3. Cell Signal. 2011 May;23(5):827-36 - PubMed
  4. Genome Biol. 2007;8(6):218 - PubMed
  5. Mol Biol Cell. 2015 Oct 1;26(19):3464-79 - PubMed
  6. Nat Rev Cancer. 2011 May;11(5):364-74 - PubMed
  7. BMC Cancer. 2014 Dec 23;14:995 - PubMed
  8. J Gastroenterol. 2013 Nov;48(11):1213-21 - PubMed
  9. Mayo Clin Proc. 2016 Mar;91(3):386-96 - PubMed
  10. PLoS One. 2015 Jul 01;10(7):e0131008 - PubMed
  11. Ann Oncol. 2012 Sep;23 (9):2289-96 - PubMed
  12. Curr Opin Oncol. 2013 Jan;25(1):50-1 - PubMed
  13. Mech Dev. 1999 Dec;89(1-2):201-9 - PubMed
  14. Bull Exp Biol Med. 2014 Oct;157(6):781-4 - PubMed
  15. Int J Oncol. 2014 May;44(5):1707-15 - PubMed
  16. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  17. Mol Cell Biol. 2007 Apr;27(7):2548-61 - PubMed
  18. PLoS Genet. 2013;9(8):e1003668 - PubMed
  19. Oncol Rep. 2008 Apr;19(4):859-63 - PubMed
  20. Genomics. 1998 Feb 15;48(1):117-20 - PubMed
  21. J Bone Miner Res. 2011 Mar;26(3):657-65 - PubMed
  22. Biochim Biophys Acta. 2013 Oct;1833(10 ):2153-64 - PubMed
  23. Arch Biochem Biophys. 2014 Dec 15;564:26-36 - PubMed
  24. J Cell Sci. 2011 Apr 15;124(Pt 8):1214-23 - PubMed
  25. J Clin Oncol. 2015 Oct 10;33(29):3305-13 - PubMed
  26. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):248-53 - PubMed
  27. BMC Complement Altern Med. 2015 Jul 03;15:212 - PubMed
  28. Nature. 2008 Nov 20;456(7220):409-12 - PubMed
  29. Sci Rep. 2015 Aug 25;5:13006 - PubMed
  30. Pathobiology. 2015 Sep;82(3-4):133-41 - PubMed
  31. Int J Cancer. 2012 Jun 1;130(11):2514-25 - PubMed
  32. Cancer Lett. 2008 Nov 28;271(2):306-13 - PubMed
  33. Curr Pharm Des. 2006;12(5):615-38 - PubMed
  34. Head Neck. 2015 Dec;37(12 ):1829-39 - PubMed

Publication Types